| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.23 | 0.002 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |